Trial Profile
Open randomized clinical study evaluating preventive treatment with doxycycline on the occurrence of folliculitis rash during treatment with erlotinib in patients with locally advanced or metastatic non-small cell lung cancer who have relapsed after first line chemotherapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Doxycycline (Primary) ; Erlotinib (Primary)
- Indications Bacterial infections; Folliculitis; Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CYTAR
- Sponsors Roche
- 01 Apr 2022 Status changed to completed, according to EudraCT record.
- 04 Jan 2012 New trial record